two alternative goals * Says scheduled meeting with FDA in Jan. 2010 * Shares up as much as 38 pct Dec 29 (Reuters) - AspenBio Pharma Inc said endpoints for the additional study of its experimental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback